Especially, the BRA have to be done thinking of the therapeutic context of the assessed drug. The reflection paper also emphasizes the uncertainties and variability of such estimations and their influence on the decision. Next, it consists of an acknowledgment of the need to aid research in the development of quantitative or semiquantitative BRA me